Evidence map›Paper›PMID 28665350›Full record

ReviewInternational journal of molecular sciences2017

Histone Lysine Methylation and Neurodevelopmental Disorders.

Jeong-Hoon Kim, Jang Ho Lee, Im-Soon Lee, Sung Bae Lee, Kyoung Sang Cho

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Brain Abnormalities in Patients with Germline Variants inAJNR. American journal of neuroradiology · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Development (Cambridge, England) · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeong-Hoon KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea. jhoonkim@kribb.re.kr.
Jang Ho LeeDepartment of Biological Sciences, Konkuk University, Seoul 05029, Korea. kingmega@konkuk.ac.kr.
Im-Soon LeeDepartment of Biological Sciences, Konkuk University, Seoul 05029, Korea. islee@konkuk.ac.kr.
Sung Bae LeeDepartment of Brain & Cognitive Sciences, DGIST, Daegu 42988, Korea. sblee@dgist.ac.kr.
Kyoung Sang ChoDepartment of Biological Sciences, Konkuk University, Seoul 05029, Korea. kscho@konkuk.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylation of several lysine residues of histones is a crucial mechanism for relatively long-term regulation of genomic activity. Recent molecular biological studies have demonstrated that the function of histone methylation is more diverse and complex than previously thought. Moreover, studies using newly available genomics techniques, such as exome sequencing, have identified an increasing number of histone lysine methylation-related genes as intellectual disability-associated genes, which highlights the importance of accurate control of histone methylation during neurogenesis. However, given the functional diversity and complexity of histone methylation within the cell, the study of the molecular basis of histone methylation-related neurodevelopmental disorders is currently still in its infancy. Here, we review the latest studies that revealed the pathological implications of alterations in histone methylation status in the context of various neurodevelopmental disorders and propose possible therapeutic application of epigenetic compounds regulating histone methylation status for the treatment of these diseases.

Indexed as

AnimalsEpigenesis, GeneticHistonesHumansLysineMethylationNeurodevelopmental DisordersProtein Processing, Post-TranslationalHistonesLysineepigenetic changeshistone lysine methylationlysine demethylaselysine methyltransferaseneurodevelopmental disorder

Identifiers

PMID28665350
PMCPMC5535897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.